Influence of Air Flow on the Performance of a Dry Powder Inhaler Using Computational and Experimental Analyses

[1]  G. Polzien.  Where we have been and where we are going: implications for home health. , 2007, Home healthcare nurse.

[2]  David F. Fletcher,et al.  The Role of Capsule on the Performance of a Dry Powder Inhaler Using Computational and Experimental Analyses , 2005, Pharmaceutical Research.

[3]  S. Anderson,et al.  Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputum , 2005, Respirology.

[4]  Judy A Raper,et al.  Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length. , 2004, Journal of pharmaceutical sciences.

[5]  John N. Staniforth,et al.  The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations I: Direct Quantification by Atomic Force Microscopy , 2004, Pharmaceutical Research.

[6]  W. Finlay,et al.  In vitro intersubject and intrasubject deposition measurements in realistic mouth-throat geometries , 2004 .

[7]  G. Scheuch,et al.  Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data. , 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[8]  Warren H. Finlay,et al.  Particle deposition measurements and numerical simulation in a highly idealized mouth-throat , 2004 .

[9]  W. Finlay,et al.  Simulation of Particle Deposition in an Idealized Mouth with Different Small Diameter Inlets , 2003 .

[10]  Mojtaba Ghadiri,et al.  Effect of the impact angle on the breakage of agglomerates: a numerical study using DEM , 2003 .

[11]  W. Finlay,et al.  Deagglomeration of dry powder pharmaceutical aerosols. , 2002, International journal of pharmaceutics.

[12]  P. Stewart,et al.  Particle Interactions Involved in Aerosol Dispersion of Ternary Interactive Mixtures , 2002, Pharmaceutical Research.

[13]  N. Chew,et al.  Characterization of pharmaceutical powder inhalers: estimation of energy input for powder dispersion and effect of capsule device configuration , 2002 .

[14]  Lars Borgström,et al.  Dry-Powder Inhalers , 2001 .

[15]  Gerald C. Smaldone,et al.  Drug Delivery to the Lung , 2001 .

[16]  S. Anderson,et al.  Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. , 2001, American journal of respiratory and critical care medicine.

[17]  C. Jenkins,et al.  Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. , 2001, American journal of respiratory and critical care medicine.

[18]  N. Chew,et al.  Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. , 2000, International journal of pharmaceutics.

[19]  Runyu Yang,et al.  Computer simulation of the packing of fine particles , 2000, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[20]  Colin Thornton,et al.  Effect of interface energy on the impact strength of agglomerates , 1999 .

[21]  V. Sharpe,et al.  Where we have been and where we are going. Sourcebook in Bioethics: a Documentary History, edited by Albert Jonsen, Robert Veatch, and LeRoy Walters; and A Companion To Bioethics, edited by Helga Kuhse, and Peter Singer. , 1999, The Hastings Center report.

[22]  Hak-Kim Chan,et al.  Influence of Particle Size, Air Flow, and Inhaler Device on the Dispersion of Mannitol Powders as Aerosols , 1999, Pharmaceutical Research.

[23]  G. Bolhuis,et al.  Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers: Part 3: the effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler , 1997 .

[24]  F. Menter.  Two-equation eddy-viscosity turbulence models for engineering applications , 1994 .

[25]  P. Beaune,et al.  Metabolism rate of oxodipine in rats and humans: comparison of in vivo and in vitro data. , 1992, The Journal of pharmacology and experimental therapeutics.

[26]  David W. Crane.  The merck index-- an encyclopedia of chemicals and drugs , 1982 .

[27]  W. Finlay,et al.  Improved numerical simulation of aerosol deposition in an idealized mouth-throat , 2004 .

[28]  S. Anderson,et al.  Use of aerosols for bronchial provocation testing in the laboratory: where we have been and where we are going. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[29]  S. Anderson,et al.  Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[30]  N. Chew,et al.  In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[31]  Warren H. Finlay,et al.  The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction , 2001 .

[32]  Bo Olsson,et al.  Calibration at Different Flow Rates of a Multistage Liquid Impinger , 1997 .

[33]  G. Rudolf,et al.  Intercomparison of Experimental Regional Aerosol Deposition Data , 1989 .

[34]  J. Crane,et al.  Reduction of the Cardiovascular Effects of Inhaled Fenoterol by Use of a Valved Holding Chamber Device , 1989 .

[35]  Susan Budavari,et al.  The Merck index : an encyclopedia of chemicals, drugs, and biologicals , 1983 .